MHUA (Meihua International Medical Technologies Co) Operating Income : $11.47 Mil (TTM As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Meihua International Medical Technologies Co Operating Income?

Meihua International Medical Technologies Co's Operating Income for the six months ended in Jun. 2024 was $5.89 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Jun. 2024 was $11.47 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. Meihua International Medical Technologies Co's Operating Income for the six months ended in Jun. 2024 was $5.89 Mil. Meihua International Medical Technologies Co's Revenue for the six months ended in Jun. 2024 was $45.34 Mil. Therefore, Meihua International Medical Technologies Co's Operating Margin % for the quarter that ended in Jun. 2024 was 12.99%.

Meihua International Medical Technologies Co's 5-Year average Growth Rate for Operating Margin % was 0.00% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Meihua International Medical Technologies Co's annualized ROC % for the quarter that ended in Jun. 2024 was 6.73%. Meihua International Medical Technologies Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 13.73%.

Meihua International Medical Technologies Co Operating Income Historical Data

The historical data trend for Meihua International Medical Technologies Co's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Meihua International Medical Technologies Co Operating Income Chart

Meihua International Medical Technologies Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Income

19.39

23.47

26.26

15.56

14.68

Meihua International Medical Technologies Co Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Operating Income	Get a 7-Day Free Trial					11.14	4.42	9.10	5.58	5.89

Meihua International Medical Technologies Co Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $11.47 Mil.

Meihua International Medical Technologies Co (NAS:MHUA) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Meihua International Medical Technologies Co's annualized ROC % for the quarter that ended in Jun. 2024 is calculated as:

	ROC % (Q: Jun. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2023 )	+	Invested Capital (Q: Jun. 2024 ))	/ count )
=	11.784 * ( 1 - 19.97% )	/	( (137.242	+	142.848)	/ 2 )
=	9.4307352	/	140.045
=	6.73 %

where

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	171.915	-	17.746	-	( 16.927	-	max(0, 25.073	-	132.237	+	16.927	))
=	137.242

	Invested Capital		(Q: Jun. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	179.163	-	17.824	-	( 18.491	-	max(0, 29.59	-	141.314	+	18.491	))
=	142.848

Note: The Operating Income data used here is two times the semi-annual (Jun. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Meihua International Medical Technologies Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Jun. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2023		Q: Jun. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	12.03	/	( ( (8.838 + max(77.111, 0))	+	(8.19 + max(81.083, 0)) )	/	2 )
=	12.03	/	( ( 85.949	+	89.273 )	/	2 )
=	12.03	/	87.611
=	13.73 %

where Working Capital is:

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(79.027	+	1.617	+	14.213)	-	(17.746	+	0	+	0)
=	77.111

	Working Capital		(Q: Jun. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(83.35	+	1.092	+	14.464)	-	(17.824	+	0	+	-0.0010000000000012)
=	81.083

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

3. Operating Income is also linked to Operating Margin %:

Meihua International Medical Technologies Co's Operating Margin % for the quarter that ended in Jun. 2024 is calculated as:

Operating Margin %	=	Operating Income (Q: Jun. 2024 )	/	Revenue (Q: Jun. 2024 )
	=	5.892	/	45.344
	=	12.99 %

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.

Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.

Meihua International Medical Technologies Co Operating Income Related Terms

Thank you for viewing the detailed overview of Meihua International Medical Technologies Co's Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Meihua International Medical Technologies Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Meihua International Medical Technologies Co Ltd (NAS:MHUA) » Definitions » Operating Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

88 Tongda Road, Touqiao Town, Guangling District, Yangzhou, CHN, 225000

Website

http://www.meihuamed.com

Meihua International Medical Technologies Co Ltd is engaged in providing disposable medical devices. It serves hospitals, pharmacies, medical institutions, and medical equipment companies. Its product offerings include a Disposable Medical mask, Disposable ID Bracelet, Disposable Artificial Anal bag, Disposable Catheter, and Electonic pump among others.